| Long-Acting Pasireotide Provides Clinical Benefit to Patients with Uncontrolled Acromegaly over Continued Treatment with First‑Generation Somatostatin Analogues (SSAs): Results from Phase 3b, Open-Label Study |
|
2019 |
| Worsening of Carcinoid Syndrome during Lutetium Therapy in a Patient with Bronchial Carcinoid and Acromegaly |
|
2019 |
| A Brazilian Multicentric Study Evaluating Pregnancies Induced by Cabergoline in Patients Harboring Prolactinomas |
|
2019 |
| Collision Sellar Lesions: Coexistence of Pituitary Adenomas and Rathke Cleft Cyst |
|
2019 |
| Suprasellar Cavernous Hemangioma: Case Report |
|
2019 |
| miR-15a is associated with poor response to first-generation somatostatin receptor ligands probably due to down regulation of sst2 in sporadic somatotropinomas |
|
2018 |
| Predictors of surgical cure in non-functioning pituitary adenomas |
|
2018 |
| Treatment escape reduces effectiveness of cabergoline during long-term treatment of acromegaly in mono therapy or in association with first-generation somatostatin receptor ligands |
|
2018 |
| Growth hormone receptor polymorphism are not related to worsening of bone quality or increased risk of fractures in acromegaly |
|
2018 |
| SPORADIC PITUITARY ADENOMAS PATIENTS PRESENTING WITH APOPLEXY: CLINICAL, RADIOLOGICAL AND GENETIC ANALYSIS |
|
2018 |
| HEADACHE IN PITUITARY ADENOMAS: FREQUENCY, CHARACTERISTICS AND ASSOCIATED FACTORS. |
|
2018 |
| MANAGEMENT OF GIANT PROLACTINOMAS: A SINGLE-CENTER EXPERIENCE |
|
2018 |
| EARLY POST-OPERATIVE CORTISOL LEVELS IN CUSHING?S DISEASE ASSOCIATED WITH BIOCHEMICAL OUTCOME |
|
2018 |
| CYCLIC CUSHING?S SYNDROME DUE TO ATYPICAL THYMIC CARCINOID TUMOR: CASE REPORT AND REVIEW OF LITERATURE |
|
2018 |
| BILATERAL INFERIOR PETROSAL SINUS SAMPLING WITH DESMOPRESSIN: A SINGLE-CENTER EXPERIENCE |
|
2018 |
| CLINICOPATHOLOGICAL CHARACTERISTICS AND SURGICAL TREATMENT OUTCOME OF THYROTROPIN-SECRETING PITUITARY TUMORS: A SINGLE-CENTER EXPERIENCE |
|
2018 |
| MIR-15A IS ASSOCIATED WITH POOR RESPONSE TO FIRST-GENERATION SOMATOSTATIN RECEPTOR LIGANDS BY REGULATING SST2 EXPRESSION IN SPORADIC SOMATOTROPINOMAS |
|
2018 |
| EFFECT OF CABERGOLINE TREATMENT ON GLUCOSE LEVELS IN ACROMEGALY |
|
2018 |
| PREVALENCE AND CHARACTERIZATION OF CARDIOMYOPATHY IN PATIENTS WITH ACROMEGALY FOLLOWED -UP IN AN OUTPATIENT CLINIC OF A REFERENCE CENTER |
|
2018 |
| Long-Acting Pasireotide Provides Clinical Benefit in Patients with Acromegaly: Results from a 30-Month Analysis of the Phase 3 Paola Study |
|
2017 |
| Two-Dimensional Speckle Tracking Echocardiography Demonstrates No Effect of Active Acromegaly on Left Ventricular Strain |
|
2017 |
| Predictors of surgical cure in acromegaly |
|
2016 |
| Results of the surgical treatment of GH and ACTH secreting tumors at a single neurosurgery center |
|
2016 |
| Role of filamin A in the expression of SSTR2 and 5 in GH-producing tumors |
|
2016 |
| b-arrestin as a predictor of response to somatostatin analogues |
|
2016 |
| AIP mutations in Brazilian patients with seemingly sporadic pituitary adenomas |
|
2016 |
| Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotropinomas |
|
2016 |
| Outcome of a single-center study on 35 pregnancies in patients with prolactinoma |
|
2016 |
| Water and Sodium Balance after Sellar and Suprasellar Lesions Surgery |
|
2016 |
| Proactive Monitoring and Early Intervention in the Management of Pasireotide-Induced Hyperglycemia: Lessons from the Phase III, 24-Week Paola Study |
|
2015 |
| Biochemical Control Is Maintained with Pasireotide LAR in Patients with Acromegaly: Results from the Extension of a Randomized Phase III Study (PAOLA) |
|
2015 |
| Metformin-Based Oral Antidiabetic Therapy Is Effective at Controlling Hyperglycemia Associated with Pasireotide in Patients with Acromegaly |
|
2015 |
| Efficacy and Safety of Pasireotide Long-Acting Release (LAR) in Patients with Inadequately-Controlled Acromegaly Treated with First-Generation Somatostatin Analogues (SSA): A Study Design of a Phase IIIb Open-Label, Single Arm Trial |
|
2015 |
| What Is the Prevalence of Pituitary Macroincidentalomas in Brain Mris? |
|
2015 |
| Ipilimumab induced hypophysitis: a case report |
|
2014 |
| Rotation thromboelastometry and the hypercoagulable state in Cushing's Syndrome |
|
2014 |
| Low AIP expression may be involved in the epithelial-mesenchymal transition in sporadic somatotropinomas |
|
2014 |
| Estudo da Densidade Mineral e Microarquitetura Ósseas na Síndrome de Cushing Endógena |
|
2014 |
| Rastreio de adenomas hipofisários em uma numerosa família Brasileira com mutação do AIP |
|
2014 |
| Pericadial effusion in untreated acromegaly patients:three case reports |
|
2014 |
| Avaliação da dispersão de QT e da prevalência de arritmias em pacientes acrmegálicos |
|
2014 |
| Phase III, multicenter, randomized study (PAOLA) demonstrating that pasireotide LAR has superior efficacy over octreotide LAR and Lanreotide ATG in patients with inadequately controlled acromegaly |
|
2014 |
| Exploratory data evaluating the effect of pasireotide on GH, IGF-1, IGFBP-2, IGFBP-3, HbA1c and glucose in patients with inadequately controlled acromegaly enrolled in a 24-week study (PAOLA) |
|
2014 |
| Biochemical remission of acromegaly after withdrawal of drug treatment: preliminary data from a large prospective multicentric study |
|
2014 |
| Extended dosing intervals (EDIs) with Lanreotide Autogel/Depot 120 mg can be effective in acromegalic patients biochemically controleed with octreotide LAR 10 or 20 mg: The Lead Study |
|
2014 |
| Pituitary adenomas harboring AIP mutations exhibit phenotype-genotype correlation, but no association with the germline FGFR4 G388R variant or somatic GNAS1 mutations |
|
2014 |
| Study design of a phase IIIB multicenter, open-label, single-arm study to evaluate efficacy and safety of pasireotide in patients with acromegaly inadequately controlled with first-generation somatostatin analogues |
|
2014 |
| Increased expression of miR-34a explains the low AIP protein level present in 50% of sporadic somatotropinomas |
|
2013 |
| Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography |
|
2013 |
| Real world data in acromegaly a retrospective chart audit |
|
2013 |
| Pituitary Adenomas due to Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations: Genotypic-Phenotypic Characteristics, Screening and Prospective Diagnosis |
|
2013 |
| Disease remission after octreotide LAR withdrawal in controlled acromegalic patients without visible tumor |
|
2012 |
| Low prevalence of left ventricular hypertrophy , fibrosis and arrythmia in patients with untreated acromegaly |
|
2012 |
| Control of acromegaly without pharmacological treatment during pregnancy: A prospective study |
|
2012 |
| Glucose homeostasis in acromegalic patients treated with octreotide LAR |
|
2012 |
| Expression profile of somatostatin receptors in clinically non-functioning pituitary adenomas |
|
2012 |
| Giant cell tumor presenting as a sellar mass mimicking a pituitary adenoma |
|
2012 |
| Dopamine receptor 2 expression profile in non-functioning pituitary adenomas and correlation with in vivo response to cabergoline |
|
2012 |
| Giant Cells Tumor Presenting as a Sellar Mass Mimicking a Pituitary Macroadenoma |
|
2012 |
| In 1-Ghrelin variant, an aberrantely sliced Ghrelin variant in human pituitary tumors: Presence, functional role, and potential therapeutic value |
|
2012 |
| Pasireotide LAR and octreotide LAR maintain GH and IGF-1 suppression in patients with acromegaly: Extension of a 12-month randomized, double-blind, multicenter, phase-III study. |
|
2012 |
| Improved biochemical control in patients with acromegaly after switching from octreotide LAR to pasireotide LAR: Crossover extension of a randomized, double-blind, multicenter, phase-III study |
|
2012 |
| Activity Control of Acromegaly without Pharmacological Treatment during Pregnancy: A Prospective Study |
|
2012 |
| Rates of biochemical response in patients with acromegaly treated with a subcutaneous octreotide hydrogel implant |
|
2011 |
| Ki-67 as a Predictor of Response to Octreotide LAR in Acromegaly Independently of SSTR2 Expression |
|
2011 |
| Low Somatostatin Receptor Subtype 2 Expression Predicts the Lack of Biochemical Response of Somatotropinomas to Treatment with Somatostatin Analogs, Independently from the Expression Rate of Dopamine Receptor Subtype 2 |
|
2011 |
| Pathogenesis of GH-secreting adenomas |
|
2010 |
| Evaluation of bone mineral density, body composition and their relationship with disease activity and gonadal status in seventh-five acromegalic patients |
|
2010 |
| Low somatostatin receptor subtype 2 protein is a negative predictor of biochemical control with octreotide-LAR |
|
2010 |
| Aryl hydrocarbon receptor interacting protein is a better marker of aggressiveness in somatotropinomas than ki-67 and p53 |
|
2010 |
| Evaluation of thyroid disease in patients with acromegaly |
|
2010 |
| Prostatic disorders and acromegaly |
|
2010 |
| Aumento do diâmetro da raiz aórtica em pacientes com acromegalia comparado a controles saudáveis |
|
2010 |
| Experience with pegvisomant in a reference center for acromegaly treatment |
|
2010 |
| Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists |
|
2010 |
| Granulomatous hypophysitis mimicking pituitary adenoma: report of 2 cases |
|
2010 |
| Avaliação cardíaca após 12 meses de tratamento com octreotide LAR (OCT-LAR) em acromegálicos |
|
2010 |
| A randomized, blinded, multicenter, Phase III study to assess the efficacy and safety of pasireotide LAR versus octreotide LAR in patients with active acromegaly |
|
2010 |
| Estudo do oncogene gsp em acromegálicos e correlação com a expressão de mRNA dos receptores da somatostatina e com a resposta in vivo ao tratamento com octreotide LAR |
|
2008 |
| Níveis séricos das isoformas 20 KDA e 22 KDA do hormônio do crescimento em pacientes com acromegalia antes e depois de tratamento com octreotide LAR |
|
2008 |
| Avaliação da gordura corporal e dos níveis de leptina em pacientes com prolactinoma pré-tratamento |
|
2008 |
| Receptores de dopamina subtipo 2 e sua isofroma lomga são expressos em somatotropinomas, adenomas hipofisários clinicamente não funcionantes e hipófises humanas normais |
|
2008 |
| PROGNOSTIC FACTORS IN PRIMARY MEDICAL TREATMENT OF ACROMEGALY WITH OCTREOTIDE LAR |
|
2006 |
| PREVALÊNCIA DA APNÉIA DO SONO EM PACIENTES COM ACROMEGALIA E ANÁLISE DOS PARÂMETROS CEFALOMÉTRICOS À RESSONÂNCIA MAGNÉTICA |
|
2006 |
| AVALIAÇÃO DO METABOLISMO DA GLICOSE EM PACIENTES ACROMEGÁLICOS PRÉ E PÓS TRATAMENTO COM OCTREOTIDE LAR |
|
2006 |
| PROLACTINOMAS IN MEN - CLINICAL, DIAGNOSIS AND THERAPEUTIC ASPECTS |
|
2004 |
| DETERMINATION OF BONE MINERAL DENSITY IN MEN WITH PROLACTINOMA - A CASE - CONTROL STUDY |
|
2004 |
| PRIMARY AND ADJUVANT THERAPY WITH OCTREOTIDE LAR IN THE TREATMENT OF ACROMEGALY |
|
2004 |
| ISOLATED FAMILIAL SOMATOTROPINOMA: NARROWING THE CANDIDATE INTERVAL FOR THE IFS GENE |
|
2003 |
| pRb PROTEIN EXPRESSION IN SOMATOTROPINOMAS HAS INVERSE CORRELATION WITH GH LEVELS |
|
2003 |
| METASTATIC RENAL CARCINOMA TO THE SELLAR REGION MASKING A PITUITARY ADENOMA |
|
2003 |
| GENETIC STUDIES IN SIX FAMILIES WITH ISOLATED FAMILIAL SOMATOTROPINOMA: STRONG EVIDENCE FOR LINKAGE TO CHROMOSOME 11Q13 |
|
2002 |
| LOSS OF HETEROZYGOSITY (LOH) AT CHROMOSOME 11Q13 IN SPORADIC SOMATOTROPINOMAS AND CORRELATION WITH AGRESSIVE BEHAVIOR |
|
2002 |
| MICROSATELLITE INSTABILITY ANALYSIS IN PATIENTS WITH SPORADIC SOMATOTROPINOMAS AND CLINICAL CORRELATION |
|
2002 |
| EVALUATION OF CHROMOSOME 13Q RB1 INTRAGENIC AND EXTRAGENIC MICROSATELLITE MARKERS IN SOMATOTROPHINOMAS |
|
2002 |
| PHYSICAL DEPENDENCY AND TOLERANCE INDUCED BY TREATMENT WITH OCTREOTIDE IN PATIENTS WITH GH-SECRETING TUMORS |
|
2001 |
| OPTOCHIASMATIC TUBERCULOMA MIMICKING AN OPTIC NERVE GLIOMA |
|
2001 |
| ADENOMA CORTICOTROFICO SUBCLINICO |
|
2000 |
| ACROMEGALIA SECUNDARIA A SECRECAO ECTOPICA DE HORMONIO LIBERADOR DE HORMONIO DE CRESCIMENTO (GHRH) POR TUMOR CARCINOIDE DE PULMAO |
|
2000 |
| CARDIOPULMONAR STRESS TEST IN GROWTH HORMONE DEFICIENT ADULTS |
|
2000 |
| RARE TUMOR OF THE SELLAR REGION: A SALIVARY GLAND PLEOMORPHIC ADENOMA ARISING WITHIN A RATHKE'S CLEFT CYST |
|
2000 |
| THE HYPOTHALAMIC - PITUITARY GROWTH HORMONE (GH) AXIS OF GH RECEPTOR KNOCKOUT AND MT - HGHRH TRANSGENIC MICE: REGULATION OF PITUITARY RECEPTOR EXPRESSION LEVELS IS A COMPONENT OF GH NEGATIVE FEEDBACK. |
|
2000 |
| LOCALIZATION OF THE ISOLATED FAMILIAL SOMATOTROPINOMA GENE TO A 7.4 MB REGION AT CHROMOSOME 11Q13 BY ALLELOTYPE AND HAPLOTYPE ANALYSES |
|
1999 |
| ISOLATED FAMILIAL SOMATOTROPINOMA (IFS) IS LINKED TO CHROMOOSME 2P16 |
|
1999 |
| LOSS OF HETEROZYGOSITY ON CHROMOSOME 11Q13 IN TWO UNRELATED FAMILIES WITH ACROMEGALY/GIGANTISM UNASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE I (MEN-I). |
|
1998 |
| RESISTÊNCIA CENTRAL AO HORMÔNIO TIREOIDIANO - RELATO DE CASO |
|
1997 |
| ADENOMA VIRILIZANTE DE SUPRARRENAL |
|
1997 |
| COMBINED TEST OF PITUITARY FUNCTION (HCRH, TRH, LHRH) IN AIDS. |
|
1996 |
| PSEUDO-TUMOR HIPOFISÁRIO SECUNDÁRIO A HIPOTIREOIDISMO PRIMÁRIO |
|
1995 |
| TESTES DA FUNÇÃO TIREOIDIANA NA HEPATOPATIA CRÔNICA VIRAL: ESTUDO PILOTO DE 68 CASOS |
|
1993 |
| TESTE DO CRH HUMANO NA SIDA |
|
1993 |
| MACROADENOMA HIPOFISARIO SECRETOR DE FSH E SUB-UNIDADE ALFA |
|
1993 |
| HIPOTIROIDISMO CENTRAL COM RESPOSTA ANÔMALA DE TSH AO TRH |
|
1993 |
| ACQUIRED HYPOPHOSPHATEMIC OSTEOMALACIA |
|
1993 |
| BOCIO DIFUSO TÓXICO: COMPLICAÇÕES POS-OPERATÓRIAS |
|
1993 |
| SERUM THYROGLOBULIN EVALUATION AND FOLLOW UP IN 34 PATIENTS WITH DIFFERENTIATED THYROID CANCER |
|
1991 |
| SURGERY FOR GRAVES DISEASE IN HUCFF-UFRJ :10 YEARS EXPERIENCE |
|
1990 |
